Lactate dehydrogenase as a selection criterion for ipilimumab treatment in metastatic melanoma. (Record no. 23622379)
[ view plain ]
000 -LEADER | |
---|---|
fixed length control field | 02072 a2200649 4500 |
005 - DATE AND TIME OF LATEST TRANSACTION | |
control field | 20250516201920.0 |
008 - FIXED-LENGTH DATA ELEMENTS--GENERAL INFORMATION | |
fixed length control field | 201406s 0 0 eng d |
022 ## - INTERNATIONAL STANDARD SERIAL NUMBER | |
International Standard Serial Number | 1432-0851 |
024 7# - OTHER STANDARD IDENTIFIER | |
Standard number or code | 10.1007/s00262-014-1528-9 |
Source of number or code | doi |
040 ## - CATALOGING SOURCE | |
Original cataloging agency | NLM |
Language of cataloging | eng |
Transcribing agency | NLM |
100 1# - MAIN ENTRY--PERSONAL NAME | |
Personal name | Kelderman, Sander |
264 #0 - PRODUCTION, PUBLICATION, DISTRIBUTION, MANUFACTURE, AND COPYRIGHT NOTICE | |
Date of production, publication, distribution, manufacture, or copyright notice | 20140604 |
245 00 - TITLE STATEMENT | |
Title | Lactate dehydrogenase as a selection criterion for ipilimumab treatment in metastatic melanoma. |
Medium | [electronic resource] |
260 ## - PUBLICATION, DISTRIBUTION, ETC. | |
Name of publisher, distributor, etc. | Cancer immunology, immunotherapy : CII |
Date of publication, distribution, etc. | May 2014 |
300 ## - PHYSICAL DESCRIPTION | |
Extent | 449-58 p. |
Other physical details | digital |
500 ## - GENERAL NOTE | |
General note | Publication Type: Clinical Trial; Journal Article |
650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM | |
Topical term or geographic name entry element | Adolescent |
650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM | |
Topical term or geographic name entry element | Adult |
650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM | |
Topical term or geographic name entry element | Aged |
650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM | |
Topical term or geographic name entry element | Aged, 80 and over |
650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM | |
Topical term or geographic name entry element | Antibodies, Monoclonal |
General subdivision | therapeutic use |
650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM | |
Topical term or geographic name entry element | Biomarkers, Tumor |
General subdivision | analysis |
650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM | |
Topical term or geographic name entry element | Disease-Free Survival |
650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM | |
Topical term or geographic name entry element | Female |
650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM | |
Topical term or geographic name entry element | Humans |
650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM | |
Topical term or geographic name entry element | Ipilimumab |
650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM | |
Topical term or geographic name entry element | Kaplan-Meier Estimate |
650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM | |
Topical term or geographic name entry element | L-Lactate Dehydrogenase |
General subdivision | blood |
650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM | |
Topical term or geographic name entry element | Male |
650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM | |
Topical term or geographic name entry element | Melanoma |
General subdivision | drug therapy |
650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM | |
Topical term or geographic name entry element | Middle Aged |
650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM | |
Topical term or geographic name entry element | Skin Neoplasms |
General subdivision | drug therapy |
650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM | |
Topical term or geographic name entry element | Treatment Outcome |
650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM | |
Topical term or geographic name entry element | Young Adult |
700 1# - ADDED ENTRY--PERSONAL NAME | |
Personal name | Heemskerk, Bianca |
700 1# - ADDED ENTRY--PERSONAL NAME | |
Personal name | van Tinteren, Harm |
700 1# - ADDED ENTRY--PERSONAL NAME | |
Personal name | van den Brom, Rob R H |
700 1# - ADDED ENTRY--PERSONAL NAME | |
Personal name | Hospers, Geke A P |
700 1# - ADDED ENTRY--PERSONAL NAME | |
Personal name | van den Eertwegh, Alfonsus J M |
700 1# - ADDED ENTRY--PERSONAL NAME | |
Personal name | Kapiteijn, Ellen W |
700 1# - ADDED ENTRY--PERSONAL NAME | |
Personal name | de Groot, Jan Willem B |
700 1# - ADDED ENTRY--PERSONAL NAME | |
Personal name | Soetekouw, Patricia |
700 1# - ADDED ENTRY--PERSONAL NAME | |
Personal name | Jansen, Rob L |
700 1# - ADDED ENTRY--PERSONAL NAME | |
Personal name | Fiets, Edward |
700 1# - ADDED ENTRY--PERSONAL NAME | |
Personal name | Furness, Andrew J S |
700 1# - ADDED ENTRY--PERSONAL NAME | |
Personal name | Renn, Alexandra |
700 1# - ADDED ENTRY--PERSONAL NAME | |
Personal name | Krzystanek, Marcin |
700 1# - ADDED ENTRY--PERSONAL NAME | |
Personal name | Szallasi, Zoltan |
700 1# - ADDED ENTRY--PERSONAL NAME | |
Personal name | Lorigan, Paul |
700 1# - ADDED ENTRY--PERSONAL NAME | |
Personal name | Gore, Martin E |
700 1# - ADDED ENTRY--PERSONAL NAME | |
Personal name | Schumacher, Ton N M |
700 1# - ADDED ENTRY--PERSONAL NAME | |
Personal name | Haanen, John B A G |
700 1# - ADDED ENTRY--PERSONAL NAME | |
Personal name | Larkin, James M G |
700 1# - ADDED ENTRY--PERSONAL NAME | |
Personal name | Blank, Christian U |
773 0# - HOST ITEM ENTRY | |
Title | Cancer immunology, immunotherapy : CII |
Related parts | vol. 63 |
-- | no. 5 |
-- | p. 449-58 |
856 40 - ELECTRONIC LOCATION AND ACCESS | |
Uniform Resource Identifier | <a href="https://doi.org/10.1007/s00262-014-1528-9">https://doi.org/10.1007/s00262-014-1528-9</a> |
Public note | Available from publisher's website |
No items available.